Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study

Tiange Wang(Shenyang Agricultural University), Guang Ning(Shanghai Jiao Tong University), Jieli Lu(Shanghai Jiao Tong University), Linhong Wang(National Center for Chronic and Noncommunicable Disease Control and Prevention), Yu Xu(Shanghai Jiao Tong University), Shenghan Lai(University of Maryland, Baltimore), Limin Wang(Binzhou Medical University), Yong Jiang(Capital Medical University), Wen­hua Zhao(National Center for Chronic and Noncommunicable Disease Control and Prevention), Di Zhang(Zhejiang International Studies University), Weiqing Wang(Nankai University), Li Y(National Center for Chronic and Noncommunicable Disease Control and Prevention), Mei Zhang(Guiyang Medical University), Baihui Xu(Zhejiang Provincial People's Hospital), Min Xu(Jiangsu University), Jichao Sun(MacroGenics (United States)), Yufang Bi(Shanghai Jiao Tong University), Lin Ding(Shanghai Jiao Tong University), Meng Dai(Fujian Medical University)
Cardiovascular Diabetology
February 25, 2015
10.1186/s12933-015-0191-6
Cited by 16

Related Papers

Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Burden of Cardiovascular Diseases in China, 1990-2016
|JAMA Cardiology|2019|749
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18
|The Lancet|2021|579
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
|Diabetes Care|2012|365
The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
|Stroke and Vascular Neurology|2019|334